B3 · BRL

AALR3

Allianca Saude e Participacoes SA - ALLIAR

R$3.30+0.61% (R$0.02)
Day's range
R$3.11 – R$3.30
Day's volume
R$220.1K
52-week range
R$2.36 – R$6.72

Follow AALR3 in the Fuolio

See how AALR3 weighs in your net worth, what it has paid you and how far it is from your target allocation.

Create a free account

AALR3 in numbers

Market cap
R$499.4M
P/E
-0.37
P/B
-1.81
Dividend yield (12m)
0.00%

AALR3 price history

10/01/202510/01/2026
Compare with

AALR3 risk and return

Monthly closes adjusted for splits and distributions.

Metric12 months36 months60 months
Return-46.69%-66.15%-77.70%
Volatility (annualized)52.64%61.77%59.90%
Largest drawdown-52.18%-81.50%-87.74%
Positive months6/1217/3633/60

How much did investing in AALR3 return?

R$1,000.00 invested on 10/01/2021 would be worth R$222.97 today.

Value today in AALR3
R$222.97
Return over the period
-77.70%
Return per year
-25.93%
In the Ibovespa
R$1,808.65

With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.

AALR3 fundamentals

Valuation

  • P/E
    -0.37
  • P/B
    -1.81
  • EV/EBITDA
    -0.92
  • EV/EBIT
    -0.82
  • EV/Revenue
    0.74
  • P/EBIT
    -0.48
  • P/S
    0.43
  • P/OCF
    2.49
  • P/FCF
    1.19
  • Earnings yield
    -122.44%
  • PEG ratio
    —
  • Earnings per share
    -R$9.01
  • Book value per share
    -R$1.82

Debt

  • Net debt
    R$351.9M
  • Net debt/EBITDA
    —
  • Net debt/Equity
    -1.40
  • Debt/Equity
    -1.86
  • Current ratio
    0.28
  • Quick ratio
    0.28
  • Cash ratio
    0.07

Efficiency

  • Gross margin
    20.76%
  • EBITDA margin
    -80.58%
  • Operating margin
    -90.34%
  • Net margin
    -118.89%
  • Asset turnover
    0.65

Profitability

  • ROE
    494.46%
  • ROA
    -77.18%
  • ROIC
    -1,045.42%
  • Payout
    —

Growth

  • Revenue CAGR (5 years)
    4.43%
  • Earnings CAGR (5 years)
    —
  • Revenue growth (year)
    -5.19%
  • Earnings growth (year)
    -1,014.96%
  • Revenue growth (quarter)
    -5.19%
  • Earnings growth (quarter)
    -1,014.96%

AALR3's indicators by year

Multiples at each year's closing price; margins and returns from that year's statements.

Indicator20252024202320222021202020192018
P/E-0.56-10.58-5.40-10.89-301.90-13.0950.5238.15
P/B-3.051.151.302.531.401.041.581.18
EV/EBITDA—8.6513.5143.3012.7019.2311.4210.63
Dividend yield0.00%0.00%0.00%0.00%0.00%1.57%0.47%—
Earnings per share-R$9.01-R$0.81-R$1.93-R$1.98-R$0.05-R$0.85R$0.36R$0.35
Book value per share-R$1.66R$7.46R$7.98R$8.55R$10.53R$10.65R$11.49R$11.31
ROE544.08%-10.83%-24.14%-23.20%-0.47%-7.96%3.13%3.08%
ROIC-1,045.42%6.48%2.20%-1.36%3.32%-0.44%4.92%4.79%
Gross margin20.76%29.22%30.93%30.02%31.33%17.80%26.55%26.87%
EBITDA margin-80.58%18.15%12.90%7.90%18.28%11.85%24.28%20.42%
Net margin-118.94%-10.11%-19.32%-21.00%-0.49%-10.49%3.85%3.72%
Net debt/EBITDA—2.755.4314.344.527.643.413.68

AALR3's financial statements

Line202520242023202220212020
Net revenueR$1.2BR$1.2BR$1.2BR$1.1BR$1.1BR$928.8M
Cost of revenue-R$914.3M-R$861.3M-R$814.8M-R$759.3M-R$780.5M-R$763.5M
Gross profitR$239.5MR$355.7MR$364.8MR$325.7MR$356MR$165.3M
EBITDA-R$929.7MR$220.8MR$152.2MR$85.7MR$207.8MR$110.1M
EBIT-R$1BR$113MR$38.9M-R$32MR$88.2M-R$9.1M
Financial result-R$233.2M-R$208.5M-R$238.4M-R$201.2M-R$85.7M-R$63.9M
Income before tax-R$1.3B-R$95.5M-R$199.5M-R$233.2MR$2.5M-R$73.1M
Income tax-R$84.2M-R$15.8M-R$19.1MR$14M-R$468K-R$19.4M
Net income-R$1.4B-R$123.1M-R$227.9M-R$227.8M-R$5.6M-R$97.4M

Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.

AALR3 against its sector

The same indicators for the company's other shares and the sector's largest stocks.

StockP/EP/BDividend yield (12m)ROEMarket cap
AALR3Alliança-0.37-1.810.00%494.46%R$499.4M
RDOR3REDE DOR SÃO LUIZ S.A.17.824.1510.97%23.26%R$86B
SAUD3SAUD337.262.103.04%5.63%R$39.3B
FLRY3FLEURY S.A.18.452.405.47%13.00%R$13B
DASA3DIAGNOSTICOS DA AMERICA S.A.-5.510.720.00%-13.09%R$4.9B
HAPV3HAPVIDA PARTICIPACOES E INVESTIMENTOS SA-19.830.070.00%-0.36%R$3.4B
MATD3HOSPITAL MATER DEI S/A11.931.132.97%9.50%R$1.7B

Does AALR3 pay dividends?

Dividend yield per year

  • 0.47%2019
  • 1.57%2020
  • 0.00%2021
  • 0.00%2022
  • 0.00%2023
  • 0.00%2024
  • 0.00%2025
  • 0.00%2026
Payment history
TypeLast day to ownPaymentPer share
Dividend12/09/202012/18/2020R$0.09
Dividend04/27/202012/18/2020R$0.09
Dividend04/25/201905/07/2019R$0.06
Dividend04/25/201905/07/2019R$0.03

About Alliança

Sector
Saúde
Segment
Serv.Méd.Hospit..Análises e Diagnósticos
Average daily trading
R$168.1K

A Alliança Saúde e Participações S.A. (AALR3), conhecida historicamente como Alliar, atua no segmento de medicina diagnóstica no Brasil, com serviços de imagem, análises clínicas e exames especializados. A companhia opera por meio de rede própria e unidades parceiras, atendendo pacientes particulares, operadoras de saúde e contratos corporativos. O modelo de negócios combina prestação ambulatorial, suporte diagnóstico hospitalar e gestão de capacidade técnica para diferentes regiões do país. No ambiente de mercado, a empresa concorre com grupos de diagnóstico de maior escala e com operadores regionais, em um setor com pressão de custos, regulação sanitária e necessidade contínua de investimento em equipamentos e sistemas. Sua operação depende de eficiência de agenda, produtividade de exames e negociação com pagadores, além de padronização clínica e controle de qualidade. O foco operacional está em manter capilaridade de atendimento e sustentabilidade financeira em um segmento sensível a volume e preço.

Investor website

Questions about AALR3

How much is AALR3 today?

AALR3 is at R$3.30 (0.61% on the day), last traded on 10/01/2026.

How much did AALR3 pay in dividends in 2025?

AALR3 paid R$0.00 per share in 2025, a dividend yield of 0.00%.

What are the P/E and P/B of AALR3?

AALR3 trades at a P/E of -0.37 and a P/B of -1.81.

How much did AALR3 return in 12 months?

AALR3 returned -46.69% in 12 months, with annualized volatility of 52.64% and a largest drawdown of -52.18%.

What sector is AALR3 in?

Alliança is in the Saúde sector, Serv.Méd.Hospit..Análises e Diagnósticos segment.